Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.67 SEK | -6.32% |
|
-25.52% | -16.31% |
06-20 | Transcript : Egetis Therapeutics AB - Special Call | |
06-19 | Egetis Therapeutics AB Announces Topline Results of the Phase 2 Triac Trial II with Emcitate for MCT8 Deficiency | CI |
- Stock Market
- Equities
- EGTX Stock
- Charts Egetis Therapeutics AB
- Total Return chart